Strides Pharma Science Limited (BOM:532531)

Strides Pharma Science Statistics

Total Valuation

BOM:532531 has a market cap or net worth of INR 62.77 billion. The enterprise value is 82.82 billion.

Market Cap	62.77B
Enterprise Value	82.82B

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Dec 6, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.52%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	56.80M

Valuation Ratios

The trailing PE ratio is 1.78.

PE Ratio	1.78
Forward PE	n/a
PS Ratio	1.37
PB Ratio	2.83
P/TBV Ratio	5.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.35
EV / Sales	1.81
EV / EBITDA	10.58
EV / EBIT	14.14
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	1.04
Debt / EBITDA	2.45
Debt / FCF	n/a
Interest Coverage	2.84

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.99%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	14.94M
Profits Per Employee	11.52M
Employee Count	3,065
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-26.94%
50-Day Moving Average	647.27
200-Day Moving Average	1,012.39
Relative Strength Index (RSI)	56.54
Average Volume (20 Days)	27,588

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532531 had revenue of INR 45.79 billion and earned 35.29 billion in profits. Earnings per share was 383.79.

Revenue	45.79B
Gross Profit	26.05B
Operating Income	7.44B
Pretax Income	4.07B
Net Income	35.29B
EBITDA	9.05B
EBIT	7.44B
Earnings Per Share (EPS)	383.79

Balance Sheet

The company has 2.47 billion in cash and 23.08 billion in debt, giving a net cash position of -20.62 billion.

Cash & Cash Equivalents	2.47B
Total Debt	23.08B
Net Cash	-20.62B
Net Cash Per Share	n/a
Equity (Book Value)	22.15B
Book Value Per Share	247.04
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 56.89%, with operating and profit margins of 16.24% and 77.07%.

Gross Margin	56.89%
Operating Margin	16.24%
Pretax Margin	8.89%
Profit Margin	77.07%
EBITDA Margin	19.76%
EBIT Margin	16.24%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 864.00, which amounts to a dividend yield of 132.84%.

Dividend Per Share	864.00
Dividend Yield	132.84%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-1.52%
Shareholder Yield	131.32%
Earnings Yield	56.23%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a